NEW YORK, July 9 - Celera Genomics and the National Cancer Institute have entered into an agreement of understanding for NCI's use of Celera's databases, the organizations announced Monday.

The signed memorandum of understanding outlines the terms and conditions for individual NCI investigators to choose to purchase access to Celera's Discovery System, including analytical tools and databases such as the fruit fly, human, and mouse genomes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.